Wolverine World Wide Inc
Change company Symbol lookup
Select an option...
WWW Wolverine World Wide Inc
CAH Cardinal Health Inc
GGXXF Ggx Gold Corp
ICE Intercontinental Exchange Inc
AICAF Air China Ltd
LGF.A Lions Gate Entertainment Corp
COMM CommScope Holding Company Inc
ENVB Enveric Biosciences Inc
BAC Bank of America Corp
CANQF CanaQuest Medical Corp
Go

Consumer Discretionary : Textiles, Apparel & Luxury Goods | Small Cap Value
Company profile

Wolverine World Wide, Inc. is a designer, marketer and licensor of a range of quality casual footwear and apparel, performance outdoor and athletic footwear and apparel, kids' footwear, industrial work boots and apparel, and uniform shoes and boots. The Company operates through two segments: Wolverine Michigan Group and Wolverine Boston Group. Its Wolverine Michigan Group consists of footwear and apparel under brand names Merrell, Cat, Wolverine, Chaco, Hush Puppies, Bates uniform footwear, Harley-Davidson and Hytest safety footwear. Its Wolverine Boston Group consists of Sperry footwear, Saucony footwear and apparel, Keds footwear and the kids' footwear business, which includes the Stride Rite licensed business, as well as kids' footwear offerings from Saucony, Sperry, Keds, Merrell, Hush Puppies and Cat. Its products are marketed in approximately 170 countries, including the United States, Canada, the United Kingdom and certain countries in continental Europe and Asia Pacific.

Closing Price
$15.27
Day's Change
0.37 (2.48%)
Bid
--
Ask
--
B/A Size
--
Day's High
15.39
Day's Low
14.83
Volume
(Light)
Volume:
1,096,329

10-day average volume:
1,379,401
1,096,329

Bragar Eagel & Squire, P.C. Is Investigating Fox, Instil, Veru, and Twist and Encourages Investors to Contact the Firm

8:50 pm ET November 21, 2022 (Globe Newswire) Print
Bragar Eagel & Squire, P.C. Is Investigating Fox, Instil, Veru, and Twist and Encourages Investors to Contact the FirmGlobeNewswireNovember 22, 2022

NEW YORK, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Fox Corporation (NASDAQ: FOX, FOXA), Instil Bio, Inc. (NASDAQ: TIL), Veru Inc. (NASDAQ: VERU), and Twist Bioscience Corp (NASDAQ: TWST). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.

Fox Corporation (NASDAQ: FOX, FOXA)

In November and December of 2020, Fox News broadcasted reports stating that the U.S. election was rigged. Fox News specifically called out Smartmatic and Dominion Voting Systems, voting technology and software companies, for their alleged involvement in rigging the election. Both companies have sued Fox for defamation and other claims based on defendants' actions. The judges in both cases have upheld the lawsuits by overruling defendants' motions to dismiss, finding that Smartmatic and Dominion sufficiently pleaded facts to support their claims of defamation.

In ruling in favor of Dominion, Delaware Superior Court Judge Eric M. Davis found Dominion had shown that the Murdochs, Fox's most senior executives, may have been on notice that the conspiracy theory that rigged voting machines tilted the vote was false but let Fox News broadcast it anyway. Dominion cited in its suit a report that Rupert Murdoch spoke with Trump a few days after the election "and informed him that he had lost," the judge noted.

"These allegations support a reasonable inference that Rupert and Lachlan Murdoch either knew Dominion had not manipulated the election or at least recklessly disregarded the truth when they allegedly caused Fox News to propagate its claims about Dominion," said Davis.

These lawsuits, which seek billions of dollars, punitive damages and other relief, can deplete Fox's assets, harm Fox's reputation, and prove detrimental to Fox shareholders.

For more information on the Fox investigation go to: https://bespc.com/cases/FOX

Instil Bio, Inc. (NASDAQ: TIL)

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Instil Bio disclosed on October 31, 2022, that it had informed the FDA that it had voluntarily paused enrollment in a clinical trial due to problems in manufacturing one of its therapies. The manufacturing trouble resulted in an inability to properly dose patients in a clinical trial of ITIL-168 for advanced melanoma.

On this news, shares of Instil Bio fell by more than 33% in intraday trading.

For more information on the Instil investigation go to: https://bespc.com/cases/TIL

Veru Inc. (NASDAQ: VERU)

On November 10, 2022, Veru issued a press release announcing that the U.S. Food and Drug Administration's Pulmonary-Allergy Drugs Advisory Committee (the "Advisory Committee") voted against granting emergency use authorization for the Company's product sabizabulin for treatment of hospitalized moderate to severe COVID-19 patients who are at high risk for acute respiratory distress syndrome. Specifically, the Advisory Committee voted 8-5 that the known and potential benefits of sabizabulin do not outweigh its known and potential risks.

On this news, Veru's stock price fell sharply during intraday trading on November 10, 2022.

For more information on the Instil investigation go to: https://bespc.com/cases/VERU

Twist Bioscience Corp (NASDAQ: TWST)

Before the market opened on November 15, 2022, Scorpion Capital published a negative report on Twist entitled "A Cash-Burning Inferno That Is Not a Going Concern, Operating a Ponzi-Like Scheme That Will End In Bankruptcy. Just Another 'Synthetic Biology' Swindle, This Time With An Absurd 'Silicon DNA Chip' And Financials So Phony It May Be Criminal. Target Price: $0." The report alleges Twist is "A ticking time bomb that we believe is resorting to a Worldcom-esque accounting fraud" and "Multiple competitors internally refer to Twist's price dumping and customer subsidy scheme as a "Ponzi".

In early morning trading on November 15, 2022, Twist's stock price is down $11.42 per share to $26.59, or a drop of 30.0%.

For more information on the Twist investigation go to: https://bespc.com/cases/TWST

About Bragar Eagel & Squire, P.C.:

Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact Information:

Bragar Eagel & Squire, P.C.

Brandon Walker, Esq.

Melissa Fortunato, Esq.

(212) 355-4648

investigations@bespc.com

www.bespc.com



Primary Logo

comtex tracking

COMTEX_419443228/2010/2022-11-21T20:50:00

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.